Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001995869 | SCV002272836 | uncertain significance | Developmental and epileptic encephalopathy, 9 | 2021-04-24 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine with histidine at codon 881 of the PCDH19 protein (p.Asn881His). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and histidine. This variant is present in population databases (rs373996202, ExAC 0.03%). This variant has not been reported in the literature in individuals with PCDH19-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV001995869 | SCV003814743 | uncertain significance | Developmental and epileptic encephalopathy, 9 | 2022-05-10 | criteria provided, single submitter | clinical testing | |
Genetics and Genomic Medicine Centre, |
RCV004571891 | SCV004174934 | uncertain significance | not provided | 2021-06-16 | no assertion criteria provided | clinical testing |